Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder
Zeeshan Ali Baig, House Officer at Federal Government Polyclinic (PGMI) Islamabad, shared a post on LinkedIn about a recent article by Juan Pablo Frontroth, published in Blood Advances, adding:
“AI-designed peptide for rare bleeding disorder
AI just designed a peptide from scratch to solve a diagnostic nightmare.
Platelet-type von Willebrand disease (PT-VWD) is a rare bleeding disorder that’s frequently misdiagnosed as a similar condition.
The treatments are completely different, so misdiagnosis can make things worse.
Researchers used an algorithm to screen over 10,000 randomly generated peptides and found one (G14) that specifically targets the mutated protein causing PT-VWD.
It blocks the abnormal platelet clumping in patient samples.
This isn’t just a potential therapy.
It’s a precision diagnostic tool built by AI.”
Title: AI-generated peptides for research and clinical practice
Authors: Juan Pablo Frontroth

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 12:19Essama Telli: When a Bruise Doesn’t Heal – Recognising the Warning Signs
-
Nov 19, 2026, 11:51Wolfgang Miesbach: Beyond Episomal Gene Therapy in Haemophilia B
-
Nov 19, 2026, 11:18A First Look at WFH CCS 2027
-
Nov 19, 2026, 10:58Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report
-
Nov 19, 2026, 10:43Strengthening Plasma Management and Patient Access Across Eastern Europe – ISBT
-
Nov 19, 2026, 10:32Rana Al-Hrout: The Hemodilution Trap – Accurate Blast Assessment in Bone Marrow Biopsies
-
Nov 19, 2026, 10:29Maria Panagiota Terzi: Presenting Research on Coagulation Biomarkers in Acute Myocardial Infarction
-
Nov 19, 2026, 10:21Paola Ranalli: Hemophilia and von Willebrand Disease Advancing Care Through Multidisciplinary Collaboration
-
Nov 19, 2026, 10:11Rana Al-Hrout: Iron Deficiency in Heart Failure – Does It Matter Even Without Anemia?